Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Musculoskeletal Diseases
»
Bone Diseases
»
Osteoporosis
16. November 2026
Search
medline.ch
Osteoporosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Bone Diseases
Infections
Neoplasms
Osteoporosis
Others
Muscular Diseases
Rheumatology
Back Pain
Spinal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 1848
Articles 1 - 20 / 36947
Updates in osteoporosis medications: maximizing benefits and minimizing risks.
Am J Med Open
Okazaki KM, Wang JY, Yu EW.
PMID: 43034800 [PubMed]
Medication Adherence and Management Experience in Patients with Osteoporosis: A Convergent Mixed-Methods Study with a Focus on Poor Adherence, Based on the Necessity-Concerns Framework.
Patient Prefer Adherence
Li X, Mei Y, Gao H, Zhang F.
PMID: 43034778 [PubMed]
Percutaneous Vertebroplasty versus Non-Surgical Controls for Osteoporotic Vertebral Compression Fractures: A Systematic Review and Meta-Analysis of Pain, Fracture, and Safety Outcomes.
Ther Clin Risk Manag
Wang T, Zhou J, Wang Y.
PMID: 43034775 [PubMed]
The paradox of osteoporosis in axial spondyloarthritis: Why antiresorptives may not be enough and anabolic therapy could be prioritized.
Ther Adv Musculoskelet Dis
Ligocki P, Wojciechowski R, , Dura-Kuczy, Gajewicz-Sawicka K, Bierwagen M, S, Jeka S.
PMID: 43034450 [PubMed]
Advances in probiotics and gut microbiota-derived extracellular vesicles for the prevention and treatment of osteoporosis.
Front Nutr
Hu M, Li H, Li Y, Cao H, Dai X, Tan Y, Yu Q, Wang Z, Wu X, Xu J, Pan X.
PMID: 43032666 [PubMed]
Hepatocyte-enriched LEAP2 in relation to heel bone density and osteoporosis-related phenotypes: an exploratory genetic and translational study.
Front Endocrinol (Lausanne)
Xia Z, Bai G, Zhang X, Cai Y, Wang H, Lin X.
PMID: 43031696 [PubMed - indexed for MEDLINE]
MRI-Based Vertebral Bone Quality Score for QCT-Defined Osteoporosis: Incremental Diagnostic Value and an Exploratory 1.5-T Threshold in a Retrospective Study.
J Clin Med
Yan Z, Shao G, Deng M, Tang X, Yang M, Qu Y, Zhang H.
PMID: 43030894 [PubMed]
Association Between Long-Term Proton Pump Inhibitor Use and the Risk of Osteoporotic Fractures.
J Clin Med
Oraby A, Khalfin B, Fleisher-Berkovich S, Ben-Shabat S.
PMID: 43030542 [PubMed]
Global prevalence and risk factors of osteoporosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
BMC Public Health
Yu C, Teng X, Du W, Ma X, Yu C, Xia Y, Hui J, Xie F, Li J, Hu S.
PMID: 43026492 [PubMed - indexed for MEDLINE]
OPXrayNet: a high-precision, explainable AI framework for transformative opportunistic osteoporosis screening utilizing multi-site X-ray imaging.
Eur Radiol
Jin Q, Jia Q, Zhou X, Li Y, Xie Z, Zhang K, Wang X, Zhang Y, Ma C, Song X.
PMID: 43026332 [PubMed - as supplied by publisher]
Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats.
Bone
Kloock S, Zytner P, Geiger N, Sequeira V, Schmitt-Böhrer A, Felker J, Sarwar H, Weich A, Ignatius A, Fassnacht M, Haffner-Luntzer M, Dischinger U.
PMID: 43025770 [PubMed - as supplied by publisher]
Physical and psychosocial morbidity in pregnancy and lactation-associated osteoporosis: a comprehensive mixed-methods study.
Osteoporos Int
Gak N, Teixeira MJC, Dhillo WS, Abbara A, Keen R, Comninos AN.
PMID: 43024074 [PubMed - as supplied by publisher]
The Causal Relationship Between Cathepsin Levels and Bone Mineral Density and Osteoporosis: Evidence from Mendelian Randomization and Experimental Validation.
Curr Med Chem
Shen Y, Zhu W, Fu F, Huang J, Ji J, Wang H, Liu T, Sun P, Zhang H, Tang D.
PMID: 43023313 [PubMed - as supplied by publisher]
The complexity of skeletal fragility in overt endogenous Cushing's syndrome: how much do we know?
Front Endocrinol (Lausanne)
Voltan G, Mogno C, Contini G, Tizianel I, Ferrarese M, Camozzi V.
PMID: 43022833 [PubMed - indexed for MEDLINE]
Fracture rate and determinants of fractures and bone loss in women with postmenopausal osteoporosis discontinuing alendronate treatment: protocol for the Alendronate Discontinuation Study (ALEXIS) - a multicentre, randomised controlled trial.
BMJ Open
Gram F, Langdahl BL, Gram J, Søe K, Jørgensen NR, Hansen S, Andersen TL, Harsløf T, Folkestad L, Hermann AP.
PMID: 43020496 [PubMed - in process]
Impact of Prior Bisphosphonates Exposure on the Efficacy of Denosumab in Patients with Osteoporosis: A Prospective Cohort Study.
Endocr Pract
Chen L, Han D, Wang H, Li B, Yuan L, Wu Y, Wang Y, Rao Z, Song L.
PMID: 43020469 [PubMed - as supplied by publisher]
Advances in research on the gut microbiota-bile acid-immune homeostasis axis in the regulation of bone metabolism in osteoporosis.
Int Immunopharmacol
Jia X, Zhang Z, Hu Y, Feng M, Li G, Li Y, Li F.
PMID: 43019935 [PubMed - as supplied by publisher]
Glycolysis and Bone Formation: From Pathological Mechanisms to Regulatory Strategies.
Cell Biochem Funct
Chao S, Zhou Y, Xia J, Wu N, Zhan S, Zhang L, Liu B.
PMID: 43019083 [PubMed - indexed for MEDLINE]
A randomized controlled trial of zoledronate and oral magnesium in post-menopausal women with osteoporosis.
Magnes Res
Pickering ME, Morel V, Delay M, Macian N, Malochet S, Durif J, Sapin V, Tournadre A, Chapurlat R, Pickering G, Pereira B.
PMID: 43019001 [PubMed - as supplied by publisher]
Real-world treatment patterns following denosumab discontinuation: a descriptive epidemiological study.
Arch Osteoporos
Yoshiyama T, Fukasawa T, Masuda S, Matsuda S, Kawakami K.
PMID: 43018839 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 36947
Page 1 of 1848
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy